| Literature DB >> 33249720 |
Chris Gardiner1, Robyn Coleman2, Moniek P M de Maat3, Akbar Dorgalaleh4, Marión Echenagucia5, Robert C Gosselin6, Masahiro Ieko7, Steve Kitchen8.
Abstract
Before a new method is used for clinical testing, it is essential that it is evaluated for suitability for its intended purpose. This document gives guidance for the performance of verification, validation and implementation processes required by regulatory and accreditation bodies. It covers the planning and execution of an evaluation of the commonly performed screening tests (prothrombin time, activated partial thromboplastin time, thrombin time and fibrinogen assay), and instrument-specific issues. Advice on selecting an appropriate haemostasis analyser, planning the evaluation, and assessing the reference, interval, precision, accuracy, and comparability of a haemostasis test system are also given. A second companion document will cover specialist haemostasis testing.Entities:
Keywords: haemostasis; laboratory automation; precision
Mesh:
Year: 2020 PMID: 33249720 DOI: 10.1111/ijlh.13411
Source DB: PubMed Journal: Int J Lab Hematol ISSN: 1751-5521 Impact factor: 2.877